CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
35 hedge funds and large institutions have $14.3M invested in Crescent Biopharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
35
Holders Change
-2
Holders Change %
-5.41%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
6
Closed
5
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$31K
Top Buyers
Top Sellers
1 |
1
D.E. Shaw & Co
New York
|
$20K |
2 |
2
Two Sigma Advisers
New York
|
$114K |
3 |
3
Two Sigma Investments
New York
|
$126K |
4 |
4
Millennium Management
New York
|
$202K |
5 |
5
Charles Schwab
San Francisco,
California
|
$0 |